We are live on ! Find out more
MWVC

Morgens Waterfall Vintiadis & Co Portfolio holdings

AUM $81.2M
1-Year Est. Return 86.87%
This Fund
S&P 500
This Quarter Est. Return
+22.4%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$153M
AUM Growth
+$11.8M
Cap. Flow
-$6.91M
Cap. Flow %
-4.52%
Top 10 Hldgs %
42.93%
Holding
71
New
17
Increased
6
Reduced
18
Closed
15

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$3.58M
2
TXN icon
Texas Instruments
TXN
+$3.45M
3
SHOP icon
Shopify
SHOP
+$3.23M
4
TTWO icon
Take-Two Interactive
TTWO
+$3.19M
5
NKE icon
Nike
NKE
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 43.46%
2 Consumer Discretionary 18.24%
3 Healthcare 14.7%
4 Industrials 8.01%
5 Communication Services 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$377B
$2.69M 1.76%
10,100
+1,388
+16% +$361K
RETA
27
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.62M 1.71%
32,000
-8,000
-20% -$564K
ADMA icon
28
ADMA Biologics
ADMA
$2.03B
$2.33M 1.52%
375,000
HD icon
29
Home Depot
HD
$339B
$2.2M 1.44%
10,600
ILMN icon
30
Illumina
ILMN
$30B
$1.83M 1.2%
5,140
LH icon
31
Labcorp
LH
$24.9B
$1.74M 1.14%
11,640
-3,492
-23% -$531K
VCRA
32
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.5M 0.98%
+41,000
New +$1.34M
MA icon
33
Mastercard
MA
$500B
$1.45M 0.95%
6,500
AAPL icon
34
Apple
AAPL
$4.46T
$1.34M 0.88%
23,752
-8,000
-25% -$417K
JPM icon
35
JPMorgan Chase
JPM
$937B
$1.31M 0.85%
11,575
+7,000
+153% +$795K
TRHC
36
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1.3M 0.85%
16,000
+4,000
+33% +$293K
HRTX icon
37
Heron Therapeutics
HRTX
$96.8M
$1.23M 0.81%
39,000
BEAT
38
DELISTED
BioTelemetry, Inc.
BEAT
$1.19M 0.78%
+18,500
New +$1.03M
MDSO
39
DELISTED
Medidata Solutions, Inc.
MDSO
$1.13M 0.74%
15,400
EHTH icon
40
eHealth
EHTH
$43.8M
$1.1M 0.72%
39,000
+9,000
+30% +$239K
ADMS
41
CALL
DELISTED
Adamas Pharmaceuticals
ADMS
$1M 0.65%
+50,000
New +$1.17M
GOOG icon
42
Alphabet (Google) Class C
GOOG
$4.56T
$845K 0.55%
+14,000
New +$839K
AGN
43
DELISTED
Allergan plc
AGN
$762K 0.5%
+4,000
New +$735K
LHX icon
44
L3Harris
LHX
$51.7B
$761K 0.5%
+4,500
New +$716K
V icon
45
Visa
V
$683B
$750K 0.49%
5,000
-5,594
-53% -$795K
TXMD icon
46
TherapeuticsMD
TXMD
$23.6M
$735K 0.48%
2,240
VRML
47
DELISTED
Vermillion, Inc.
VRML
$710K 0.46%
1,000,000
BP icon
48
BP
BP
$114B
$578K 0.38%
13,126
-189
-1% -$7.9K
PFE icon
49
Pfizer
PFE
$143B
$573K 0.37%
13,702
RDS.B
50
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$553K 0.36%
7,792

Similar funds

Morgens Waterfall Vintiadis & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Morgens Waterfall Vintiadis & Co held 71 positions worth $153M, up 8.4% from $141M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Morgens Waterfall Vintiadis & Co withdrew a net $6.91M in Q3 2018, closing 15 positions and reducing 18 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $5.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Morgens Waterfall Vintiadis & Co opened a new position in Twilio worth $4.23M.

  • Morgens Waterfall Vintiadis & Co's largest Q3 2018 buy was Twilio: 49,000 shares worth $4.23M.
  • Morgens Waterfall Vintiadis & Co added most to JPMorgan Chase in Q3 2018, an estimated $795K increase.
  • Morgens Waterfall Vintiadis & Co's biggest Q3 2018 reduction was Netflix, cutting an estimated $2.11M.
  • Morgens Waterfall Vintiadis & Co fully exited Meta Platforms (Facebook) in Q3 2018, selling an estimated $5.32M.
  • Morgens Waterfall Vintiadis & Co's ten largest holdings make up 43% of its $153M portfolio in Q3 2018.
  • Morgens Waterfall Vintiadis & Co opened 17 new positions and closed 15 in Q3 2018.
  • Morgens Waterfall Vintiadis & Co's portfolio value rose 8.4% quarter-over-quarter to $153M.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.